In Brief: Cambridge Biotech
This article was originally published in The Gray Sheet
Executive Summary
Cambridge Biotech: U.S. Bankruptcy Court upholds the company's license to HIV-2 tests from Pasteur Sanofi, which had been challenged by Institut Pasteur and Genetic Systems in a patent infringement suit filed in March. However, the court enjoined Cambridge Biotech from sale of its Western Blot HIV-1 test, ruling that it infringed an Institut Pasteur patent. Cambridge Biotech, which in July 1994 filed for bankruptcy under Chapter 11 of the U.S. Bankruptcy Code, says that the court's decisions will allow it to "move forward" with its reorganization...